First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
This is the third article in a seven-part series that highlights how technology and solution integration can result in improved claim outcomes.
The International Association of Industrial Accident Boards and Commissions (IAIABC) is an association of workers’ compensation jurisdictional regu
Genex case manager Lisa Dykhoff travels 700 miles to help those affected by Oklahoma natural disasterA
Automotive headlamp technology has progressed tremendously over the past twenty years, rapidly moving beyond sealed beam and halogen headlamp assem
After an extensive public review process, the New York Workers' Compensation Board adopted its final drug formulary rule on June 5, 2019.